|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-9-4
|
|
pubmed:abstractText |
This randomized, double-blind, phase II study assessed two doses of the selective estrogen receptor modulator arzoxifene in women with advanced breast cancer. The primary end point was to choose the best of two doses of arzoxifene based on the response rate or the clinical benefit rate (CBR). Pharmacokinetics and toxicities were also assessed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BaselgaJJ,
pubmed-author:BelletMM,
pubmed-author:CarrascoEE,
pubmed-author:ChiaG AGA,
pubmed-author:Guillem-PortaVV,
pubmed-author:KayitalireLL,
pubmed-author:KerbratPP,
pubmed-author:KrejcyKK,
pubmed-author:KussPP,
pubmed-author:Llombart-CussacAA,
pubmed-author:LluchAA,
pubmed-author:NamerMM,
pubmed-author:PetruzelkaLL,
pubmed-author:VodvarkaPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1383-90
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12954577-Aged,
pubmed-meshheading:12954577-Aged, 80 and over,
pubmed-meshheading:12954577-Antineoplastic Agents, Hormonal,
pubmed-meshheading:12954577-Breast Neoplasms,
pubmed-meshheading:12954577-Chemotherapy, Adjuvant,
pubmed-meshheading:12954577-Dose-Response Relationship, Drug,
pubmed-meshheading:12954577-Endometrium,
pubmed-meshheading:12954577-Female,
pubmed-meshheading:12954577-Humans,
pubmed-meshheading:12954577-Middle Aged,
pubmed-meshheading:12954577-Piperidines,
pubmed-meshheading:12954577-Selective Estrogen Receptor Modulators,
pubmed-meshheading:12954577-Thiophenes
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.
|
|
pubmed:affiliation |
Vall D'Hebron University Hospital, Barcelona, Spian. jbaselga@vhebron.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
